HKBIO 2023 conference in Hong Kong
Last week, the vibrant energy of knowledge converged at the HKBIO2023 conference in Hong Kong! So, why should you join the next conference HKBIO2024? Because there’s a unique power in every specialized gathering, where countless open minds unite. 🧠 A…
BIOHK 2023 International Convention
Join us at BIOHK2023 International Convention, happening from September 13 to 16, 2023, in Hong Kong! 向本次会议尊贵的来宾介绍我们团队,我们深感荣幸。我们坚信,在互利合作中,我们可以助您蓬勃发展。 Adalah suatu kehormatan besar untuk memperkenalkan pasukan kami kepada para tetamu yang dihormati dalam konferens ini. Kami dengan tegas percaya bahawa dalam kerjasama…
CDISC version 2.0
Still remember the XPT file limitations? Variable names confined to 8 characters, labels capped at 40, and data restricted to 200? If you’re curious about merging metadata with data, like utilizing Define-XML / Define-JSON, we’ve got some exhilarating news for…
Analysis of Covariance
Analysis of Covariance (ANCOVA) is a statistical technique used to examine whether population means of a dependent variable are equal across different levels of a categorical independent variable, while statistically controlling for the effects of other continuous variables known as…
The FDA‘s Multiple Endpoints in Clinical Trials
📊 Within the realm of statistical analysis lies a challenging aspect that demands our close attention: the complexities of multiple comparisons. 📈 Statistical inquiry often encourages researchers to engage in exploratory analyses – a process full of opportunities. However, the…
Win Ratio and Hazard Ratio
📚 Welcome to Part 2 of our series on the “Win Ratio” methodology in clinical trials! Today, we explore the key differences between the Win Ratio and Hazard Ratio, examining their definitions, clinical trial design, endpoints, interpretation, application, focus, and…
Win Ratio An Approach to Analyzing Composite Endpoints
In this series of posts, we’ll explore the “Win Ratio” methodology’s literature review and its application in clinical trials🔍 The Win Ratio, introduced in 2012, analyzes composite endpoints based on clinical priorities [1]. It prioritizes clinically significant events by calculating…
Menu